-
Foley Hoag Represents Kyruus in Acquisition of HealthSparq from Cambia Health Solutions
January 11, 2021 -
Foley Hoag Represents Pear Therapeutics, Inc. in $80M Series D Financing
December 18, 2020 -
Foley Hoag Expands Labor & Employment Practice in New York with Addition of Robert P. Haney Jr. as Partner
December 7, 2020 -
Foley Hoag Represents Organogenesis Holdings in $64.7M Follow-On Offering
December 1, 2020 -
Foley Hoag Partner Hemmie Chang Honored as 2020 Top Woman of Law by Massachusetts Lawyers Weekly
November 18, 2020 -
Foley Hoag Expands Licensing & Strategic Alliances Practice in New York with Addition of Marcus Sands as Counsel
September 28, 2020 -
Foley Hoag Represents Dogma Therapeutics in Sale of Its Oral PCSK9 Inhibitor Program to AstraZeneca
September 17, 2020 -
Foley Hoag Represents Glympse Bio in $46.7M Series B Financing
July 23, 2020 -
Foley Hoag Secures Court of Appeals Win for Dana-Farber Cancer Institute on Inventorship of Groundbreaking Cancer Immunotherapy Patents
July 16, 2020 -
Foley Hoag Advises RTW Investments and Ji Xing Pharmaceuticals on IP Matters in Royalty Monetization and Strategic Licensing Agreement with Cytokinetics for Up to $450 Million in Upfront and Milestone Payments
July 15, 2020
Showing 1 - 10 of 204